Answers are grounded in this paper and cite their sources.
PURPOSE: To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. METHODS: This retrospective study at the Medical University of Vienna included patients with DME who were switched from aflibercept 2 mg to faricimab. IRF dynamics and central subfield thickness (CST) were assessed after two faricimab injections. Eyes were categorized as prior responders or non-responders based on their anatomical response to the last aflibercept injection (≥20% CST reduction or CST ≤250 μm). Optical coherence tomography (OCT)-derived CST and quantitative IRF volumes were analysed at baseline and after two faricimab injections. Associations between CST and IRF changes were evaluated. RESULTS: Fifty-eight eyes of 45 patients (mean age 65.3 ± 10 years) were included, with 56 eyes previously treated with aflibercept. After two faricimab injections (mean follow-up 10.1 ± 2.2 weeks), CST and total IRF volume decreased significantly (p < 0.0001). CST reduction was strongly associated with IRF reduction in the central millimetre (estimate 1.00 [0.73-1.28], p < 0.0001), but less so with total IRF volume (estimate 0.22 [0.17-0.28], p < 0.0001). Responders (n = 28) showed greater CST reduction compared to non-responders (-105.6 ± 123.9 μm vs. -27.3 ± 60.1 μm; p = 0.0003) and lower total IRF volume after treatment (p = 0.029), with more consistent regional improvements. Non-responders showed smaller but still significant IRF reductions. CONCLUSIONS: Switching from aflibercept 2 mg to faricimab resulted in significant reductions in CST and IRF volumes after two injections with a more pronounced effect in previous responders. While CST closely reflected central changes, its weaker association with total IRF reduction indicates that quantitative fluid assessment may further refine evaluation of treatment response and retreatment decisions.
No takes yet. Share an insight, caveat, or question.
Stino et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: